In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging global population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the forecast period, the market will maintain growth at a CAGR of in the single-digits.

Abstract
The full report suite on the European market for cardiac rhythm management, electrophysiology and cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, electrophysiology (EP) lab systems, diagnostic EP catheters and cardiac ablation catheters.